Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human SHARP1 ELISA Kit (AC3833)
Cat.#: ASET-2422
Specifications
Description Human SHARP1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human SHARP1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 2.58 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 40-640 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1448 Human Wnt3 ELISA Kit (AC2859) Quantitative inquiry ASET-1473 Human NTE ELISA Kit (AC2884) Quantitative inquiry ASET-1508 Mouse Aromatase ELISA Kit (AC2919) Quantitative inquiry ASET-1272 Porcine TIMP1 ELISA Kit (AC2683) Quantitative inquiry ASET-2016 Dehydroepiandrosterone ELISA Kit (AC3427) Quantitative inquiry ASET-2404 Porcine TSH ELISA Kit (AC3815) Quantitative inquiry ASET-2073 Human P2Y2 ELISA Kit (AC3484) Quantitative inquiry ASET-1667 Rat Vimentin ELISA Kit (AC3078) Quantitative inquiry ASET-1690 Human Aspartate beta Hydroxylase ELISA Kit (AC3101) Quantitative inquiry ASET-1539 Rabbit Estradiol ELISA Kit (AC2950) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket